Skip to Main Content

Paper Details

Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Front Immunol
9
2020
Author NameAffiliation
Susan HolmesStanford University
  • 1 - 1

Datasets

Release 1.2